Akebia Therapeutics Inc (AKBA)
1.81
+0.02
(+1.12%)
USD |
NASDAQ |
Nov 21, 16:00
1.81
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Market Cap: 394.91M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 390.54M |
| November 19, 2024 | 397.09M |
| November 18, 2024 | 392.73M |
| November 15, 2024 | 390.54M |
| November 14, 2024 | 405.82M |
| November 13, 2024 | 418.91M |
| November 12, 2024 | 425.45M |
| November 11, 2024 | 434.18M |
| November 08, 2024 | 423.27M |
| November 07, 2024 | 406.91M |
| November 06, 2024 | 436.36M |
| November 05, 2024 | 405.82M |
| November 04, 2024 | 403.64M |
| November 01, 2024 | 357.51M |
| October 31, 2024 | 351.16M |
| October 30, 2024 | 359.62M |
| October 29, 2024 | 361.74M |
| October 28, 2024 | 344.81M |
| October 25, 2024 | 336.35M |
| October 24, 2024 | 334.24M |
| October 23, 2024 | 336.35M |
| October 22, 2024 | 346.93M |
| October 21, 2024 | 289.81M |
| October 18, 2024 | 283.47M |
| October 17, 2024 | 281.35M |
| Date | Value |
|---|---|
| October 16, 2024 | 281.35M |
| October 15, 2024 | 277.12M |
| October 14, 2024 | 279.24M |
| October 11, 2024 | 279.24M |
| October 10, 2024 | 270.77M |
| October 09, 2024 | 270.77M |
| October 08, 2024 | 279.24M |
| October 07, 2024 | 279.24M |
| October 04, 2024 | 281.35M |
| October 03, 2024 | 279.24M |
| October 02, 2024 | 283.47M |
| October 01, 2024 | 270.77M |
| September 30, 2024 | 279.24M |
| September 27, 2024 | 279.68M |
| September 26, 2024 | 279.68M |
| September 25, 2024 | 277.58M |
| September 24, 2024 | 283.89M |
| September 23, 2024 | 275.48M |
| September 20, 2024 | 288.09M |
| September 19, 2024 | 288.09M |
| September 18, 2024 | 283.89M |
| September 17, 2024 | 288.09M |
| September 16, 2024 | 294.40M |
| September 13, 2024 | 307.02M |
| September 12, 2024 | 302.82M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
45.99M
Minimum
Nov 29 2022
1.944B
Maximum
Jun 30 2020
441.82M
Average
322.46M
Median
Market Cap Benchmarks
| Corcept Therapeutics Inc | 5.863B |
| Eli Lilly and Co | 711.90B |
| Bioventus Inc | 753.04M |
| NovaBay Pharmaceuticals Inc | 3.508M |
| Palatin Technologies Inc | 17.79M |
Market Cap Related Metrics
| PS Ratio | 2.171 |
| Price | 1.81 |
| Earnings Yield | -12.53% |